SavedAdd your journal

Journals / Infectious diseases and clinical microbiology (Online) / 2021 / Cilt: 3 - Sayı: 3

Diagnostic Value of Non-specific Clinical and Laboratory Findings in Patients Suspected of Crimean-Congo Hemorrhagic Fever in an Endemic Region

Aziz Ahmad HAMİDİ
Serhat KESCİOĞLU
Pages
145–151
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When the association of multiple findings were assessed, the highest sensitivity was found for myalgia plus transaminase elevation (Odds ratio [OR] 9.3; 95% confidence interval [CI] 3.75-23.05; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: We aimed to determine diagnostic sensitivity and specificity of clinical and laboratory findings in patients with Crimean-Congo hemorrhagic fever (CCHF).
📊
Key Findings & Data:Results: Mean age of 125 patients included (55.2% women, 44.8% men) was 47±20 years.
💡
Conclusion & Impact:When the association of multiple findings were assessed, the highest sensitivity was found for myalgia plus transaminase elevation (Odds ratio [OR] 9.3; 95% confidence interval [CI] 3.75-23.05; p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: We aimed to determine diagnostic sensitivity and specificity of clinical and laboratory findings in patients with Crimean-Congo hemorrhagic fever (CCHF). Methods: We retrospectively reviewed the characteristics of patients who were suspected of CCHF. The patients were stratified into two groups as positive and negative based on results of CCHF specific IgM and viral RNA by real-time polymerase chain reaction (RT-PCR). Results: Mean age of 125 patients included (55.2% women, 44.8% men) was 47±20 years. The highest sensitivity (95%) was in myalgia. When the association of multiple findings were assessed, the highest sensitivity was found for myalgia plus transaminase elevation (Odds ratio [OR] 9.3; 95% confidence interval [CI] 3.75-23.05; p

🔖

Cite This Article

HAMİDİ, A. A., KESCİOĞLU, S. (2022). Diagnostic Value of Non-specific Clinical and Laboratory Findings in Patients Suspected of Crimean-Congo Hemorrhagic Fever in an Endemic Region. Infectious diseases and clinical microbiology (Online), Cilt: 3 - Sayı: 3, 145–151. https://ajindex.com/articles/539068

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. 1 Leblebicioglu H, Ozaras R, Irmak H, Sencan I. Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges. Antiviral Res. 2016
  2. [CrossRef] 2 Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006
  3. 6(4):203-14. [CrossRef] 3 Fillâtre P, Revest M, Tattevin P. Crimean-Congo hemorrhagic fever: An update. Med Mal Infect. 2019
  4. 49(8):574-85. [CrossRef] 4 Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis. 2009
  5. 13(3):380-6. [CrossRef] 5 Yagci-Caglayik D, Korukluoglu G, Uyar Y. Seroprevalence and risk factors of Crimean-Congo hemorrhagic fever in selected seven provinces in Turkey. J Med Virol. 2014
  6. 86(2):306-14. [CrossRef] 6 Ertugrul B, Uyar Y, Yavas K, Turan C, Oncu S, Saylak O, et al. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Int J Infect Dis. 2009
  7. 13(6):e431-6. [CrossRef] 7 Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006
  8. 12(6):551-4. [CrossRef] 8 Kilinc C, Guckan R, Capraz M, Varol K, Zengin E, Mengeloglu Z, et al. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2016
  9. 53(2):162-7. 9 Papa A. Diagnostic approaches for Crimean-Congo hemorrhagic fever virus. Expert Rev Mol Diagn. 2019
  10. 19(6):531-6. [CrossRef] 10 Sagmak-Tartar A, Balin SO, Akbulut A, Demirdag K. Crimean Congo Hemorrhagic Fever in Eastern Turkey: Epidemiological and Clinical Evaluation. Turkiye Parazitol Derg. 2019
  11. 43(1):26-9. Turkish. [CrossRef] 11 Leblebicioglu H, Sunbul M, Guner R, Bodur H, Bulut C, Duygu F, et al. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect. 2016
  12. 22(4):387.e1- 387.e4. [CrossRef] 12 Pshenichnaya NY, Sydenko IS, Klinovaya EP, Romanova EB, Zhuravlev AS. Possible sexual transmission of Crimean-Congo hemorrhagic fever. Int J Infect Dis. 2016
  13. [CrossRef] 13 Ergonul O, Celikbas A, Yildirim U, Zenciroglu A, Erdogan D, Ziraman I, et al. Pregnancy and Crimean-Congo haemorrhagic fever. Clin Microbiol Infect. 2010
  14. 16(6):647-50. [CrossRef] 14 Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southea